Search research articles
Contact Us
Filters
Showing results (111-120 of 135) with videos related to
Page
of 14
Sort By:
JCO Clinical Cancer Informatics
|
July 1, 2022
Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415
Rahul Khairnar, Lyudmila DeMora, Howard M Sandler, et al.
The Lancet. Oncology
|
October 15, 2018
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial
Mack Roach, Jennifer Moughan, Colleen A F Lawton, et al.
Plos One
|
April 14, 2021
Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415
Rahul Khairnar, Stephanie L Pugh, Howard M Sandler, et al.
European Urology Focus
|
February 2, 2024
Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202
Kimberley S Mak, Molly Scannell Bryan, James J Dignam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2021
Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in <sup>11</sup>C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer
Henan Zhang, Jacob J Orme, Feven Abraha, et al.
The New England Journal of Medicine
|
February 2, 2017
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer
William U Shipley, Wendy Seiferheld, Himanshu R Lukka, et al.
The New England Journal of Medicine
|
October 21, 2005
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
Edward H Romond, Edith A Perez, John Bryant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2020
Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis
Daniel E Spratt, Shawn Malone, Soumyajit Roy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 31, 2020
NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer
William A Hall, Eric Paulson, Brian J Davis, et al.
JCO Precision Oncology
|
July 8, 2026
Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology
Sophia C Kamran, Monica Borges, Jeff Michalski, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 135) with videos related to
Sort By:
Page
of 14
JCO Clinical Cancer Informatics
|
July 1, 2022
Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415
Rahul Khairnar, Lyudmila DeMora, Howard M Sandler, et al.
The Lancet. Oncology
|
October 15, 2018
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial
Mack Roach, Jennifer Moughan, Colleen A F Lawton, et al.
Plos One
|
April 14, 2021
Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415
Rahul Khairnar, Stephanie L Pugh, Howard M Sandler, et al.
European Urology Focus
|
February 2, 2024
Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202
Kimberley S Mak, Molly Scannell Bryan, James J Dignam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 2021
Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in <sup>11</sup>C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer
Henan Zhang, Jacob J Orme, Feven Abraha, et al.
The New England Journal of Medicine
|
February 2, 2017
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer
William U Shipley, Wendy Seiferheld, Himanshu R Lukka, et al.
The New England Journal of Medicine
|
October 21, 2005
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
Edward H Romond, Edith A Perez, John Bryant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2020
Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis
Daniel E Spratt, Shawn Malone, Soumyajit Roy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 31, 2020
NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer
William A Hall, Eric Paulson, Brian J Davis, et al.
JCO Precision Oncology
|
July 8, 2026
Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology
Sophia C Kamran, Monica Borges, Jeff Michalski, et al.
Page
of 14